Have your own idea? Try our Stock Screener
U.S. Drug Retail Industry Analysis
UpdatedNov 14, 2025
DataAggregated Company Financials
Companies9
- 7D14.5%
- 3M3.3%
- 1Y-11.6%
- YTDn/a
The Drug Retail industry is up 14% in the last week, with Ridgetech up 84%. Meanwhile, Mangoceuticals actually underperformed within the industry, shrinking 29% in the last week. In the past year, the industry is down 12%.
Industry Valuation and Performance
Has the U.S. Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 18 Nov 2025 | US$109.4m | US$2.2b | -US$28,710,490.78 | 20.8x | -3.8x | 0.05x |
| Thu, 16 Oct 2025 | US$1.6b | US$3.5b | -US$120,233,153.79 | 25.8x | -13.7x | 0.5x |
| Sat, 13 Sep 2025 | US$2.0b | US$3.5b | -US$119,460,717.58 | 18.2x | -16.9x | 0.6x |
| Mon, 11 Aug 2025 | US$11.8b | US$158.0b | -US$6,422,791,258.24 | 73.8x | -1.8x | 0.07x |
| Wed, 09 Jul 2025 | US$11.5b | US$158.1b | -US$6,426,932,581.66 | 33.7x | -1.8x | 0.07x |
| Fri, 06 Jun 2025 | US$11.2b | US$155.4b | -US$5,907,847,282.43 | n/a | -1.9x | 0.07x |
| Sun, 04 May 2025 | US$11.2b | US$155.3b | -US$5,913,791,131.99 | n/a | -1.9x | 0.07x |
| Tue, 01 Apr 2025 | US$11.1b | US$153.8b | -US$8,968,805,358.43 | n/a | -1.2x | 0.07x |
| Thu, 27 Feb 2025 | US$11.2b | US$153.8b | -US$8,983,678,188.26 | n/a | -1.2x | 0.07x |
| Sat, 25 Jan 2025 | US$11.9b | US$153.8b | -US$8,983,746,618.24 | n/a | -1.3x | 0.08x |
| Mon, 23 Dec 2024 | US$9.7b | US$151.0b | -US$8,784,148,978.82 | n/a | -1.1x | 0.06x |
| Wed, 20 Nov 2024 | US$8.9b | US$151.0b | -US$8,794,947,906.61 | n/a | -1x | 0.06x |
| Fri, 18 Oct 2024 | US$10.8b | US$151.0b | -US$8,683,645,299.61 | 77.8x | -1.2x | 0.07x |
| Sun, 15 Sep 2024 | US$8.0b | US$147.8b | -US$5,892,495,958.97 | n/a | -1.4x | 0.05x |
| Tue, 13 Aug 2024 | US$9.3b | US$147.8b | -US$5,884,368,943.66 | n/a | -1.6x | 0.06x |
| Thu, 11 Jul 2024 | US$9.4b | US$147.8b | -US$5,905,420,760.29 | n/a | -1.6x | 0.06x |
| Sat, 08 Jun 2024 | US$13.8b | US$146.9b | -US$6,131,688,470.50 | n/a | -2.3x | 0.09x |
| Mon, 06 May 2024 | US$15.5b | US$146.9b | -US$6,142,350,372.31 | 38.5x | -2.5x | 0.1x |
| Wed, 03 Apr 2024 | US$17.0b | US$146.9b | -US$6,124,973,457.48 | 33.7x | -2.8x | 0.1x |
| Fri, 01 Mar 2024 | US$18.4b | US$144.7b | US$499.5m | 32.3x | 36.9x | 0.1x |
| Sun, 28 Jan 2024 | US$19.9b | US$144.8b | US$444.9m | 36.8x | 44.7x | 0.1x |
| Tue, 26 Dec 2023 | US$22.9b | US$141.4b | -US$3,209,348,662.00 | 50.1x | -7.1x | 0.2x |
| Thu, 23 Nov 2023 | US$18.5b | US$164.8b | -US$4,844,590,344.00 | 49.2x | -3.8x | 0.1x |
| Sat, 21 Oct 2023 | US$18.7b | US$141.3b | -US$3,218,014,066.00 | 361.3x | -5.8x | 0.1x |
| Mon, 18 Sep 2023 | US$19.7b | US$138.4b | -US$3,448,694,294.00 | 361.3x | -5.7x | 0.1x |
| Wed, 16 Aug 2023 | US$25.1b | US$138.3b | -US$3,447,850,871.00 | 361.3x | -7.3x | 0.2x |
| Fri, 14 Jul 2023 | US$26.1b | US$138.4b | -US$3,449,019,273.00 | 361.3x | -7.6x | 0.2x |
| Sun, 11 Jun 2023 | US$27.5b | US$135.5b | -US$3,271,735,243.00 | n/a | -8.4x | 0.2x |
| Tue, 09 May 2023 | US$27.6b | US$135.5b | -US$3,266,579,431.00 | n/a | -8.5x | 0.2x |
| Thu, 06 Apr 2023 | US$31.5b | US$135.5b | -US$3,266,711,964.00 | n/a | -9.6x | 0.2x |
| Sat, 04 Mar 2023 | US$31.4b | US$134.2b | -US$3,076,272,474.00 | n/a | -10.2x | 0.2x |
| Mon, 30 Jan 2023 | US$32.4b | US$134.3b | -US$3,077,362,247.00 | n/a | -10.5x | 0.2x |
| Wed, 28 Dec 2022 | US$33.3b | US$134.7b | US$4.2b | 7.6x | 7.9x | 0.2x |
| Fri, 25 Nov 2022 | US$36.4b | US$134.7b | US$4.2b | 8.3x | 8.7x | 0.3x |
Price to Earnings Ratio
8.7x
Current Industry PE
- Investors are pessimistic on the American Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.15x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 75% per year, which is driving profits down.
Industry Comparison
How does U.S. Drug Retail compare with similar industries?
| US Market | -0.39% | |
| Consumer Staples | 0.63% | |
| Food and Staples Retail | 0.11% | |
| Drug Retail | 14.48% | |
| Food Retail | 3.07% | |
| Big Box Super Stores | -0.0054% | |
| Food Distributors | -1.87% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RDGT Ridgetech | US$3.87 | 84.3% +US$18.6m | 92.5% | PS0.3x | |
| SRXH SRx Health Solutions | US$0.24 | 16.2% +US$854.7k | n/a | PS0.09x |